Crown Equity Holdings Inc. (OTCBB:CRWE.OB) recently announced that it has launched its crwenewswire.fr website to provide news in France’s native language. Crown Equity Holdings Inc. had previously launched its German website crwenewswire.de and is launching its Canadian website crwenewswire.ca shortly.
“The new website is one step in many towards the company goal of expanding its footprint internationally, ” commented Kenneth Bosket, President and CEO of Crown Equity Holdings Inc. “Our goal for 2010 is to have all CRWE’s clients’ press releases, articles and news content published in every major financial country’s native language, as well as within cities of every state of our country,” stated Mr. Bosket.
Crown Equity Holdings is a news service containing news from around the world, and an advertising media, consisting of : crownequityholdings.com, CRWEnewswire.com, DrStockPick.com, CRWEfinance.com, CRWESelect.com, CRWEpicks.com, BestOTC.com , Stock-PR.com, PennyOmega.com, PennyToBuck.com, StockHotTips.com, CRWEwallstreet.com, Doubleinstocks.com, Crowntradingsystems.com.
Crown Equity Holdings, Inc. is a consulting organization which provides and assists small business owners with the knowledge required in taking their company public, and has re-focused its primary vision with its aligned group of independent website divisions to providing media advertising services, as a worldwide online media advertising publisher, dedicated to the distribution of quality branding information, as well as search engine optimization for its clients.
EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company focused on the development of ENMD-2076, its proprietary Aurora A/angiogenic kinase inhibitor for the treatment of cancer, reports that on September 7, 2010 it entered into a securities purchase agreement with a group of strategic investors for gross proceeds of approximately $5.1 million. The Company expects to complete the offering on or about September 8, 2010. The financing will provide capital to fund operations through 2011 and enable the Company to move forward with expansion of development plans for ENMD-2076, which is currently in Phase 1 and Phase 2 clinical trials. The ongoing Phase 2 trial of ENMD-2076 in ovarian cancer patients continues on track and the Company looks forward to the presentation of data early in 2011.
The investor group was led by Tak W. Mak, Ph.D., Director of The Campbell Family Institute for Cancer Research, and includes scientific advisors to EntreMed as well as experienced investors who have expertise both in oncology drug development and in drug development in the China markets. Concurrent with the execution of the securities purchase agreement, EntreMed entered into a rights agreement with Selected Value Therapeutics I, LLC (SVT) pursuant to which SVT has an option to exercise, on behalf of the investors, certain license, development and commercialization rights for ENMD-2076 in China, enabling the Company to leverage the experience and access that these investors have in this growing market. If the option is exercised, EntreMed will be entitled to receive development milestone payments and royalties on future product sales within the geographic market. The option is exercisable at any time until December 31, 2011.
EntreMed, Inc. is a clinical-stage pharmaceutical company committed to developing ENMD-2076, a selective angiogenic kinase inhibitor, for the treatment of cancer. ENMD-2076 is currently in a multi-center Phase 2 study in ovarian cancer and in several Phase 1 studies in solid tumors, multiple myeloma, and leukemia.
Entropic Communications, Inc. (Nasdaq:ENTR), a leading provider of silicon and software solutions to enable connected home entertainment, reports the pricing of an underwritten public offering of 10,750,000 shares of its common stock at a price to the public of $9.70 per share. The offering is expected to close on or about October 5, 2010, subject to customary closing conditions. The Company has also granted the underwriters a 30-day option to purchase up to an additional 1,612,500 shares to cover over-allotments, if any. All of the shares in the offering are being offered by the Company. Barclays Capital Inc. and J.P. Morgan Securities LLC are acting as the joint book-running managers for the offering and Craig-Hallum Capital Group LLC, Signal Hill Capital Group LLC, Pacific Crest Securities LLC and Merriman Capital, Inc. are acting as co-managers.
Entropic Communications, Inc. is a leading fabless semiconductor company that is engineering the future of connected home networking and entertainment by providing next-generation silicon and software technologies to the world’s leading cable, telecommunications and satellite service providers, OEMs and consumer electronics manufacturers.
Envestnet, Inc. (NYSE: ENV), a leading independent provider of technology-enabled investment and practice management solutions to financial advisors, recently reported financial results for its second quarter ended June 30, 2010.
Financial results for the second quarter of 2010 compared to the second quarter of 2009:
Revenue increased 37% to $24.3 million for the second quarter of 2010 from $17.7 million for the second quarter of 2009
Net income attributable to common stockholders was $0.1 million, or $0.01 per diluted share, for the second quarter of 2010 compared to $0.2 million, or $0.01 per diluted share, for the second quarter of 2009
Adjusted EBITDA(1) increased 122% to $4.5 million for the second quarter of 2010 from $2.0 million for the second quarter of 2009
Adjusted Net Income(1) increased 190% to $1.8 million for the second quarter of 2010 from $0.6 million for the second quarter of 2009
�We are very pleased with our second quarter results and the recent completion of our IPO,� said Jud Bergman, founder and chief executive officer of Envestnet. �Our performance reflects Envestnet empowering a growing number of advisors to better serve their clients with an integrated wealth management platform that enables the fiduciary process.�
Envestnet, Inc. is a leading independent provider of technology-enabled investment and practice management solutions to financial advisors who are independent, as well as those who are associated with small or mid-sized financial advisory firms and larger financial institutions. Envestnet�s technology is focused on addressing financial advisors� front-, middle- and back-office needs. Envestnet is headquartered in Chicago.
No comments :
Post a Comment